The Carlyle Group and China’s Meinian Onehealth Healthcare Holdings have made an undisclosed investment in Chinese clinical laboratory operator Adicon Holding Limited, making the duo the company’s single largest shareholders, said Carlyle in a statement today. According to the statement, equity for the investment came from Carlyle Asia Partners V, Carlyle’s flagship US$6.55 billion fund […]

Carlyle Co-Leads Investment In Chinese Clinical Labs Operator Adicon appeared first on China Money Network.